FDM - ETF AI Analysis
Top Page
First Trust Dow Jones Select MicroCap Index Fund (FDM)
FDM vs. SPDR S&P 500 ETF (SPY)
- AUM
- 264.67M
- Region
- North America
- Expense Ratio
- 0.60%
- Beta
- 0.90
- Issuer
- First Trust
- Inception Date
- Sep 27, 2005
- Dividend Yield
- 1.53%
- Asset Class
- Equity
- Index Tracked
- DJ Select Micro-Cap
FDM Summary
FDM (First Trust Dow Jones Select MicroCap Index Fund) is an ETF that tracks the Dow Jones Select Micro-Cap Index, focusing on very small U.S. companies. These “micro-cap” firms are early-stage or niche businesses across many sectors, with a big tilt toward financial and industrial companies. Top holdings include names like Stoke Therapeutics and Deluxe. Investors might consider FDM if they want growth potential and diversification beyond the usual large, well-known stocks. However, micro-cap stocks can be very volatile and harder to trade, so the fund’s price can swing sharply and may drop more than the overall market.
How much will it cost me?
The expense ratio for the First Trust Dow Jones Select MicroCap Index Fund (FDM) is 0.6%, which means you’ll pay $6 per year for every $1,000 invested. This is higher than average because the fund is actively managed and focuses on micro-cap stocks, which require more research and management compared to passive funds tracking larger companies.
What would affect this ETF?
The First Trust Dow Jones Select MicroCap Index Fund (FDM) could benefit from economic growth and innovation in the U.S., particularly in sectors like financials and technology, which make up a significant portion of its holdings. However, micro-cap stocks are highly sensitive to market volatility, interest rate hikes, and economic downturns, which could negatively impact the fund's performance. Additionally, regulatory changes or challenges in key sectors like healthcare and energy may pose risks to its future growth.
FDM Top 10 Holdings
FDM is essentially a micro-cap hunting ground with a heavy tilt toward U.S. financials, and that’s where much of the story sits. Regional players like Orrstown Financial, Heritage Insurance, and GCM Grosvenor have been generally rising this year, helping to pull the fund higher even as their short-term moves look a bit mixed. On the growth side, PagerDuty has been steadily climbing, adding a tech spark, while Seneca Foods has been a quiet powerhouse despite some recent wobbling. Biotech names like Arbutus Biopharma are more of a wild card, occasionally dragging on performance. Overall, it’s a U.S.-centric, finance-heavy portfolio with a few innovative outliers trying to juice returns.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 PD | PagerDuty | 2.17% | $5.73M | $1.33B | 5.77% | 63Neutral |
 QNST | Quinstreet | 1.46% | $3.86M | $951.05M | 10.89% | 69Neutral |
 RIGL | Rigel | 1.51% | $3.98M | $898.69M | 61.48% | 78Outperform |
 APOG | Apogee | 1.51% | $3.97M | $912.72M | 10.03% | 64Neutral |
 HRTG | Heritage Insurance Holdings | 1.45% | $3.82M | $1.10B | 62.13% | 72Outperform |
 REPX | Riley Exploration Permian | 1.36% | $3.59M | $1.08B | 83.80% | 78Outperform |
 PAHC | Phibro Animal Health | 1.37% | $3.60M | $1.58B | -5.31% | 64Neutral |
 ORRF | Orrstown Financial Services | 1.39% | $3.68M | $828.09M | 28.49% | 81Outperform |
 IBCP | Independent Bank | 1.32% | $3.48M | $806.50M | 12.01% | 78Outperform |
 SMP | Standard Motor Products | 1.30% | $3.43M | $828.15M | -9.25% | 65Neutral |
FDM Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FDM, the sentiment is Positive. The current price of 89.45 is above the 20-day moving average (MA) of 88.57, below the 50-day MA of 90.63, and above the 200-day MA of 87.30, indicating a neutral trend. The MACD of -0.37 indicates Negative momentum. The RSI at 51.34 is Neutral, neither overbought nor oversold. The STOCH value of 59.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FDM.
FDM Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| FDM | $89.45 | $98.00(9.56% Upside) | $264.67M | 0.60% | 69Neutral |
 CVLC | $95.36 | $115.95(21.59% Upside) | $995.59M | 0.15% | 73Outperform |
 AAUB | $51.16 | $61.56(20.33% Upside) | $845.44M | 0.10% | 69Neutral |
 HLAL | $74.32 | $90.34(21.55% Upside) | $971.11M | 0.50% | 76Outperform |
 DFMC | $57.83 | $72.66(25.64% Upside) | $201.94M | 0.41% | 62Neutral |
 BUSM | $15.35 | $27.08(76.45% Upside) | $112.89M | 0.73% | 54Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FDM | First Trust Dow Jones Select MicroCap Index Fund | 89.45 | 15.69 | 21.27% | |
| CVLC | Calvert US Large-Cap Core Responsible Index ETF | 95.36 | 13.54 | 16.55% | |
| AAUB | Alpha Architect US Equity 4 ETF | 51.16 | 1.67 | 3.38% | |
| HLAL | Wahed FTSE USA Shariah ETF | 74.32 | 13.80 | 22.80% | |
| DFMC | U.S. Micro Cap Portfolio ETF | 57.83 | 8.82 | 17.99% | |
| BUSM | EA Bridgeway Ultra-Small Company Market ETF | 15.35 | -1.04 | -6.32% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.